Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: A prospective study

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurology

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004150200041PMID 11967655
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concentric Contraction of the Visual Field in Patients with Temporal Lobe Epilepsy and Its Association with the Use of Vigabatrin Medication

  2000cited by this paper
• Outer retinal dysfunction in patients treated with vigabatrin.

  2000cited by this paper
• Prevalence of epilepsy in rural Bolivia

  1999cited by this paper
• Characteristics of a Unique Visual Field Defect Attributed to Vigabatrin

  1999cited by this paper
• Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

  1999cited by this paper
• Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.

  1998cited by this paper
• Vigabatrin-associated retinal cone system dysfunction

  1998cited by this paper
• Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.

  1997cited by this paper
• Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent.

  1997cited by this paper
• Severe persistent visual field constriction associated with vigabatrin

  1997cited by this paper
• No Effect of Long‐Term Vigabatrin Treatment on Central Nervous System Conduction in Patients with Refractory Epilepsy: Results of a Multicenter Study of Somatosensory and Visual Evoked Potentials

  1997cited by this paper
• Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.

  1997cited by this paper
• Afferent visual function after single dose application of -vinyl GABA

  1995cited by this paper
• Diazepam and its effects on visual fields.

  1992cited by this paper
• Effects of Long‐Term Vigabatrin on Somatosensory‐Evoked Potentials in Epileptic Patients

  1989cited by this paper
• Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients.

  1989cited by this paper
• Normal variability of static perimetric threshold values across the central visual field.

  1987influential reference
• A Study of the Effects of Vigabatrin on the Central Nervous System and Retina of Sprague Dawley and Lister-Hooded Rats

  1987cited by this paper
• Demonstration unseres neuen Projektionskugelperimeters samt theoretischen und klinischen Bemerkungen über Perimetrie

  1946cited by this paper
• [Not Available].

  1946cited by this paper

• The Gamma-Aminobutyric Acid B Receptor in Depression and Reward.

  2018cites this paper
• VIGABATRIN TOXICITY IN INFANCY IS ASSOCIATED WITH RETINAL DEFECT IN ADOLESCENCE: A Prospective Observational Study

  2017cites this paper
• Vigabatrin: Lessons Learned From the United States Experience

  2017cites this paper
• Retinal structure and function in vigabatrin‐treated adult patients with refractory complex partial seizures

  2016cites this paper
• Association Between Electroretinogram-identified Vigabatrin Toxicity and Subsequent Visual Field Reduction

  2014cites this paper
• Some long-term outcomes of visual dysfunction arising from vigabatrin ocular toxicity

  2014cites this paper
• Relationship between the area of isopters and Vigabatrin dosage during two years of observation

  2014cites this paper
• A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.

  2013cites this paper
• Evolution of visual field loss over ten years in individuals taking vigabatrin.

  2013cites this paper
• The effect of antiepileptic drugs on the evoked potentials of children with epilepsy

  2012cites this paper
• Visual field and ocular safety during short-term vigabatrin treatment in cocaine abusers.

  2012cites this paper
• Vigabatrin for childhood partial-onset epilepsies.

  2012cites this paper
• Vigabatrin-associated Visual Field Loss

  2012cites this paper
• Retinal nerve fiber layer thickness in Vigabatrin‐exposed patients

  2011cites this paper
• Registry initiated to characterize vision loss associated with vigabatrin therapy.

  2011cites this paper
• Understanding and interpreting vision safety issues with vigabatrin therapy

  2011cites this paper
• Peripapillary retinal nerve fibre layer thickness in individuals with epilepsy exposed to vigabatrin

  2011cites this paper
• Evidence-based Review of Recommendations for Visual Function Testing in Patients Treated with Vigabatrin

  2010cites this paper
• GABAB receptors in reward processes.

  2010cites this paper
• What’s New in the Treatment of Cocaine Addiction?

  2010cites this paper
• Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review

  2010cites this paper
• Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy

  2010cites this paper
• Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy.

  2010cites this paper
• Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin

  2009cites this paper
• Antiepileptic Drugs in the Treatment ofDrugUseDisorders

  2008cites this paper
• The Search for Medications to Treat Stimulant Dependence

  2008cites this paper
• PART 4 – The role of electrophysiology and psychophysics in ocular toxicology

  2008cites this paper
• Candidate Medications for Stimulant Dependence MEDICATION Abstinence Initiation Medications Modafinil Propranolol Bupropion Relapse Prevention Medications GABA Enhancers

  2008cites this paper
• Vigabatrin-attributable visual field defects in patients with intractable partial epilepsy.

  2006influential citation
• A pharmacogenetic exploration of vigabatrin-induced visual field constriction.

  2006cites this paper
• Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.

  2006cites this paper
• Vigabatrin Retinopathy in an Irish Cohort: Lack of Correlation with Dose

  2006cites this paper
• Haplotype mapping in epilepsy genetics and pharmacogenetics.

  2006cites this paper
• Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

  2005cites this paper
• Safety and efficacy of γ‐vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction

  2005cites this paper
• [Efficacy and tolerability of vigabatrin in West syndrome].

  2005cites this paper
• Avaliação da eficácia e tolerabilidade da vigabatrina na síndrome de West

  2005cites this paper
• New medications for the treatment of cocaine dependence.

  2005cites this paper
• The effect of antiepileptic drugs on visual performance.

  2004cites this paper
• The specialist nurse role in the treatment of refractory epilepsy.

  2004cites this paper
• Treatment of Partial Seizures in Childhood

  2004cites this paper
• Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship.

  2004cites this paper
• Neue Antiepileptika – ihr Stellenwert in der aktuellen Therapie

  2003influential citation
• Treating cocaine addiction: From preclinical to clinical trial experience with γ‐vinyl GABA

  2003cites this paper
• Characterization of vigabatrin-associated optic atrophy.

  2003cites this paper
• Sub-chronic low dose γ-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine

  2003cites this paper
• Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.

  2003cites this paper
• Short‐term Nonhormonal and Nonsteroid Treatment in West Syndrome

  2003cites this paper
• Gesichtsfelddefekte unter Vigabatrin: Update

  2002cites this paper
• Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.

  2002cites this paper
• Rapid development of visual field defects associated with vigabatrin therapy

  2001cites this paper
• Visual Field Defects and Other Ophthalmological Disturbances Associated with Vigabatrin

  2001cites this paper
• Infantile Spasms in Down Syndrome: Good Response to a Short Course of Vigabatrin

  2001cites this paper